BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caddy SL, Vaysburd M, Papa G, Wing M, O'Connell K, Stoycheva D, Foss S, Terje Andersen J, Oxenius A, James LC. Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity. EMBO J 2021;40:e106228. [PMID: 33258165 DOI: 10.15252/embj.2020106228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Janssens Y, Joye J, Waerlop G, Clement F, Leroux-roels G, Leroux-roels I. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Front Immunol 2022;13:959379. [DOI: 10.3389/fimmu.2022.959379] [Reference Citation Analysis]
2 Phatarphekar A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, Kuchroo P, Shinde K, Masand G, Pagare S, Khadpe N, Pai SS, Vijayan V, Ramnath RL, Pratap Reddy K, Rao P, Harinarayana Rao S, Ramana V. RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice. Vaccine 2022:S0264-410X(22)00775-7. [PMID: 35718590 DOI: 10.1016/j.vaccine.2022.06.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Foss S, Jonsson A, Bottermann M, Watkinson R, Lode HE, McAdam MB, Michaelsen TE, Sandlie I, James LC, Andersen JT. Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Sci Immunol 2022;7:eabj1640. [PMID: 35486676 DOI: 10.1126/sciimmunol.abj1640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Leroux-Roels I, Waerlop G, Tourneur J, De Boever F, Maes C, Bruhwyler J, Guyon-Gellin D, Moris P, Del Campo J, Willems P, Leroux-Roels G, Le Vert A, Nicolas F. Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine. Front Immunol 2022;13:852904. [PMID: 35464450 DOI: 10.3389/fimmu.2022.852904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Erol A. Importance of Efferocytosis in COVID-19 Mortality. IDR 2022;Volume 15:995-1007. [DOI: 10.2147/idr.s348639] [Reference Citation Analysis]
6 Sahin M, Remy MM, Fallet B, Sommerstein R, Florova M, Langner A, Klausz K, Straub T, Kreutzfeldt M, Wagner I, Schmidt CT, Malinge P, Magistrelli G, Izui S, Pircher H, Verbeek JS, Merkler D, Peipp M, Pinschewer DD. Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors. Cell Rep 2022;38:110303. [PMID: 35108544 DOI: 10.1016/j.celrep.2022.110303] [Reference Citation Analysis]
7 Yilmaz IC, Ipekoglu EM, Bulbul A, Turay N, Yildirim M, Evcili I, Yilmaz NS, Guvencli N, Aydin Y, Gungor B, Saraydar B, Bartan AG, Ibibik B, Bildik T, Baydemir İ, Sanli HA, Kayaoglu B, Ceylan Y, Yildirim T, Abras I, Ayanoglu IC, Cam SB, Ciftci Dede E, Gizer M, Erganis O, Sarac F, Uzar S, Enul H, Adiay C, Aykut G, Polat H, Yildirim IS, Tekin S, Korukluoglu G, Zeytin HE, Korkusuz P, Gursel I, Gursel M. Development and preclinical evaluation of virus-like particle vaccine against COVID-19 infection. Allergy 2022;77:258-70. [PMID: 34519053 DOI: 10.1111/all.15091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
8 Castillo-Olivares J, Wells DA, Ferrari M, Chan ACY, Smith P, Nadesalingam A, Paloniemi M, Carnell GW, Ohlendorf L, Cantoni D, Mayora-Neto M, Palmer P, Tonks P, Temperton NJ, Peterhoff D, Neckermann P, Wagner R, Doffinger R, Kempster S, Otter AD, Semper A, Brooks T, Albecka A, James LC, Page M, Schwaeble W, Baxendale H, Heeney JL. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases. Front Immunol 2021;12:748291. [PMID: 34867975 DOI: 10.3389/fimmu.2021.748291] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Nawab DH. Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects. Hum Vaccin Immunother 2021;:1-14. [PMID: 34844516 DOI: 10.1080/21645515.2021.1985891] [Reference Citation Analysis]
10 Cassone A, Cauda R. Multicomponent vaccines to fight SARS-CoV-2 variants of concern. Vaccine 2021;39:6969-71. [PMID: 34743927 DOI: 10.1016/j.vaccine.2021.10.069] [Reference Citation Analysis]
11 Withanage K, De Coster I, Cools N, Viviani S, Tourneur J, Chevandier M, Lambiel M, Willems P, Le Vert A, Nicolas F, Van Damme P. Phase 1 randomized, placebo-controlled, dose-escalating study to evaluate OVX836, a nucleoprotein-based influenza vaccine: intramuscular results. J Infect Dis 2021:jiab532. [PMID: 34653245 DOI: 10.1093/infdis/jiab532] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Benn JA, Mukadam AS, McEwan WA. Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease. Semin Cell Dev Biol 2021:S1084-9521(21)00247-0. [PMID: 34654628 DOI: 10.1016/j.semcdb.2021.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ireland G, Jeffery-Smith A, Zambon M, Hoschler K, Harris R, Poh J, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Aiano F, Amin-Chowdhury Z, Letley L, Jones SEI, Kall M, Patel M, Gopal R, Borrow R, Linley E, Amirthalingam G, Brown KE, Ramsay ME, Ladhani SN. Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England. EClinicalMedicine 2021;41:101150. [PMID: 34608455 DOI: 10.1016/j.eclinm.2021.101150] [Reference Citation Analysis]
14 Sood A, Raghavan S, Batra P, Sharma K, Talwar A. Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection. Med Hypotheses 2021;156:110681. [PMID: 34601231 DOI: 10.1016/j.mehy.2021.110681] [Reference Citation Analysis]
15 Jones EL, Laidlaw SM, Dustin LB. TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease. Front Immunol 2021;12:738473. [PMID: 34552597 DOI: 10.3389/fimmu.2021.738473] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Albecka A, Clift D, Vaysburd M, Rhinesmith T, Caddy SL, Favara DM, Baxendale HE, James LC. A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein. EMBO J 2021;40:e108588. [PMID: 34323299 DOI: 10.15252/embj.2021108588] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
17 Caddy S, Papa G, Borodavka A, Desselberger U. Rotavirus research: 2014-2020. Virus Res 2021;304:198499. [PMID: 34224769 DOI: 10.1016/j.virusres.2021.198499] [Reference Citation Analysis]
18 Liao Y, Zhang Y, Zhao H, Pu J, Zhao Z, Li D, Fan S, Yu L, Xu X, Wang L, Jiang G, Liu L, Li Q. Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine. Emerg Microbes Infect 2021;10:1112-5. [PMID: 34057040 DOI: 10.1080/22221751.2021.1937328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
19 Tascioglu D, Akkaya E, Genc S. The understanding of the immunopathology in COVID-19 infection. Scand J Clin Lab Invest 2021;81:255-63. [PMID: 34032527 DOI: 10.1080/00365513.2021.1892817] [Reference Citation Analysis]
20 Wang Z, Yang L, Chen Y, Xu Z, Wang H, Zhang X. A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study. J Thorac Dis 2021;13:2986-3000. [PMID: 34164190 DOI: 10.21037/jtd-20-3011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Zeng J, Santos AF, Mukadam AS, Osswald M, Jacques DA, Dickson CF, McLaughlin SH, Johnson CM, Kiss L, Luptak J, Renner N, Vaysburd M, McEwan WA, Morais-de-Sá E, Clift D, James LC. Target-induced clustering activates Trim-Away of pathogens and proteins. Nat Struct Mol Biol 2021;28:278-89. [PMID: 33633400 DOI: 10.1038/s41594-021-00560-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
22 Caddy SL, Vaysburd M, Papa G, Wing M, O'Connell K, Stoycheva D, Foss S, Terje Andersen J, Oxenius A, James LC. Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity. EMBO J 2021;40:e106228. [PMID: 33258165 DOI: 10.15252/embj.2020106228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]